Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Live Discussions
Live Discussions

Updated 21 December 2006

The Functional Roles of APP Cytoplasmic Domain—Conflicts and Consensus


Sanjay Pimplikar
The amyloid-β-yielding extracellular domain of APP has gotten most of the attention over the last decade or so, but inside the cell there is a large cytoplasmic fragment that might be the key to understanding the true nature of APP.

Sanjay Pimplikar led this live discussion on 3 October 2006. Readers are invited to submit additional comments by using our Comments form at the bottom of the page.

View Transcript of Live Discussion — Posted 21 December 2006


Background Text
By Sanjay W. Pimplikar

The amyloid-β precursor protein (APP) cytoplasmic domain exists in three forms—as a part of uncleaved APP, as a part of the membrane-associated C-terminal fragments, and as a free, soluble fragment termed the APP intracellular domain (AICD). Though the cytoplasmic domain has lived in relative obscurity compared to its better-known half, the Aβ peptide, interest in the domain has been aroused by recent reports that addressed its biological roles. The APP cytoplasmic domain interacts with Fe65 (1), along with several other proteins, and the significance of this domain (and that of its interaction with Fe65) was revealed when APP double or triple (APP, APLP1, and APLP2) knockout mice (2) were found to have a similar phenotype as the Fe65 double knockout animals (3). Fe65 associates with both intact APP and free AICD, and the exact mechanism underlying cortical dysplasia seen in these knockout animals poses an exciting challenge in the field.

The APP cytoplasmic domain attracted immense attention with the observations that AICD regulates gene expression (4, 5, and ARF related news story), and a number of studies have since come to similar conclusions. Because it has been difficult to identify the gene targets of AICD, and a recent study has cast doubts about its transcriptional role (6), the debate over AICD’s role in transcriptional regulation is likely to continue in the near future. However, the biological effects of the APP cytoplasmic domain and/or its proteolytic fragments are less uncertain. The observation that a point mutation in the APP cytoplasmic tail (that potentially abolishes the generation of C31 fragment by caspases) rescues memory deficits (7 and ARF related news story) in a mouse model of AD is a significant observation that should prompt re-evaluation of how we look at the etiology of the disease.

It is likely that the APP cytoplasmic domain exerts biological effects as a part of APP-CTFs (such as C99 and C83), although this area of research remains less studied. Another area of interest is the role of phosphorylation of the APP cytoplasmic domain on the T668 residue, its effect on AICD-mediated transcription, and its association with interacting proteins such as Fe65, Dab1, and x11-α. Two recent papers studied the role of T668 phosphorylation and came to opposite conclusions regarding nuclear translocation of AICD and its role in transcription (8,9). In summary, as with other areas of AD research, the studies on APP cytoplasmic domain have generated conflicting and sometimes contradictory views.

The aim of this live discussion is to bring researchers together to discuss the issues related to the APP cytoplasmic domain as a prelude to a mini-symposium on the same topic at the forthcoming SfN meeting in Atlanta (Tuesday, October 18, 8:30 a.m.). Some of the items up for discussion will include the following:

  • Does AICD play a role in gene expression? If so, how?
  • What is the role of the APP cytoplasmic domain and Fe65 in cortical dysplasia or neuronal migration?
  • How does phosphorylation of T668 regulate APP function? What role does Pin1 play, since it binds to the phosphorylated form of APP?
  • How does a mutation in the APP cytoplasmic domain (D664A) reduce the memory deficits in a mouse model of AD?

References:
1. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, de Candia P, De Renzis S, Faraonio R, Sabo S, Cheetham J, Sudol M, Russo T. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's β-amyloid precursor proteins. J Biol Chem. 1997 Mar 7;272(10):6399-405. Abstract

2. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Müller U. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 2004 Oct 13;23(20):4106-15. Abstract

3. Guénette S, Chang Y, Hiesberger T, Richardson JA, Eckman CB, Eckman EA, Hammer RE, Herz J. Essential roles for the Fe65 amyloid precursor protein-interacting proteins in brain development. EMBO J. 2006 Jan 25;25(2):420-31. Abstract

4. Cao X, Südhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 2001 Jul 6;293(5527):115-20. Abstract

5. Gao Y, Pimplikar SW. The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14979-84. Abstract

6. Hébert SS, Serneels L, Tolia A, Craessaerts K, Derks C, Filippov MA, Müller U, De Strooper B. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 2006 Jul ;7(7):739-45. Abstract

7. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, Greenberg DA, Bredesen DE. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci U S A. 2006 May 2;103(18):7130-5. Abstract

8. Nakaya T, Suzuki T. Role of APP phosphorylation in Fe65-dependent gene transactivation mediated by AICD. Genes Cells. 2006 Jun ;11(6):633-45. Abstract

9. Chang KA, Kim HS, Ha TY, Ha JW, Shin KY, Jeong YH, Lee JP, Park CH, Kim S, Baik TK, Suh YH. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol. 2006 Jun ;26(11):4327-38. Abstract



  Submit a Comment on this Live Discussion
Cast your vote and/or make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.

View Webinar Instructions

Early Detection Survey Results
The Alzheimer Disease Early Detection Surveys were designed to gauge perceptions and knowledge of early detection of Alzheimer disease as a follow-up to our Early Detection Webinar. The surveys were developed in collaboration with the Geoffrey Beene Foundation.
View Researcher Survey Results [.pdf].
View Public Survey Results [.pdf].
AlzPossible Initiative
The AlzPossible Initiative is an innovative "center without walls" that enables skilled individuals to share their knowledge about best practices in Alzheimer caregiving through this open forum.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad